Skip to content

Swiss Chinese Law Association — Geneva

SCLA | Swiss Chinese Law Association

Legal Observatory / Everyday Rights

Explained China Hong Kong SAR Rules in force

Hong Kong Public Healthcare Fee Reform: HA Clarifies Outpatient Consultation Charges and Medication Units

Hong Kong's Secretary for Health answered Legislative Council questions clarifying consultation fee policies for rescheduled prescriptions, fee waiver statistics, and medication charging units under the public healthcare fee reform.

What Changed

  • Secretary for Health presented 10-month performance metrics for Hong Kong's healthcare fee reform implemented on January 1, 2026.
  • Hospital Authority clarified that doctor reviews for rescheduled prescriptions require clinical reassessments, justifying consultation fee charges.
  • Outpatient medication chargeable units were confirmed at four-week intervals, subject to ongoing biennial reviews.

### Background

On November 18, 2026, the Secretary for Health, Professor Lo Chung-mau, responded to a Legislative Council question (LCQ4) raised by the Hon Chan Hok-fung regarding public healthcare fees and charges reform in Hong Kong SAR. The first phase of the fees and charges reform for public healthcare came into effect on January 1, 2026. Implemented by the Hospital Authority (HA), the reform strategically restructures public healthcare subsidies to allocate limited financial and manpower resources toward four specific categories of patients: "poor, acute, serious, critical," while aiming to reduce wastage and misuse.

Following the implementation of the reform, members of the public raised enquiries and complaints concerning specific charging arrangements, such as consultation fees charged when patients receive additional medication following rescheduled appointments, as well as the chargeable units applied to outpatient prescriptions.

### System Performance Across Target Categories

During the first 10 months of 2026, implementation of the reform across the four key patient categories yielded the following statistical outcomes:

1. **Poor Patients**: The medical fee waiver mechanism was expanded. The number of individuals granted full waivers increased from under 14,000 annually in past years to over 250,000. In the first 10 months of 2026, approximately $900 million in medical fees was waived.

2. **Acute Care Services**: Category IV (Semi-urgent) and Category V (Non-urgent) attendances at Accident and Emergency (A&E) departments decreased by 7.0 percent compared to the same period in the prior year, with non-urgent attendances dropping by 17.5 percent. Category I (Critical) and Category II (Emergency) cases were fully exempted from A&E fees, involving approximately $30 million in waived fees over 10 months. Treatment timing targets were fully met, providing immediate treatment for critical cases and care within 15 minutes for emergency cases.

3. **Serious Illnesses**: An annual spending cap of $10,000 was established without requiring a financial assessment. As of end-October 2026, approved applications exceeded 24,000 patients, with approximately $200 million in fees waived.

4. **Critical Illnesses**: The HA added 26 new drugs to its Drug Formulary within 10 months, 13 of which are government-subsidised, representing an estimated additional annual expenditure of about $192 million. Furthermore, 31 proposals for new drugs/devices/clinical indication relaxations and 26 self-financed devices were brought under the Samaritan Fund (SF). Approved SF subsidies expanded year-on-year to $2.2 billion for drug items (+19 percent) and $360 million for non-drug items (+16 percent).

### What the Rules Require

#### Prescription after Rescheduling vs. Staged Medication Collection

The HA highlighted that charging arrangements for medication requested without a face-to-face consultation are separate from the fee reform and rely on two established mechanisms:

* **Prescription after Rescheduling**: Applies when a patient initiates appointment rescheduling or fails to attend a scheduled follow-up consultation and requires additional medication. Although no face-to-face consultation occurs, a doctor must review the patient's medical history and assess their clinical condition to confirm suitability before prescribing. Because this assessment constitutes a clinical consultation service, the patient must pay the standard outpatient consultation fee. Consultation fees are waived only under exceptional circumstances not caused by the patient, such as clinic suspensions due to severe weather. The HA recorded zero complaints on this issue in 2023 and 2024, one complaint in 2025, and one complaint during the first 10 months of 2026.

* **Staged Medication Collection**: Applies to clinically stable chronic disease patients receiving long-term prescriptions (e.g., over six months). Dispensing is carried out in stages by the pharmacy to ensure medication safety and avoid excessive home storage. The patient pays the consultation fee only when submitting the initial prescription. Subsequent refills under the same prescription incur no additional consultation fees, as no further medical consultation takes place.

#### Medication Chargeable Units

Under the fee reform, the HA reduced the chargeable unit for outpatient prescribed medication from 16 weeks to four weeks per prescribed drug. This model aligns charging with the quantity of medication dispensed while accounting for administrative costs and operational efficiency. The HA conducts biennial reviews of charging arrangements, including medication units and models, under its established mechanism.

### Practical Implications

Patients requesting additional medication outside of regular scheduled visits due to personal rescheduling should anticipate paying standard outpatient consultation fees, as medical record reviews and clinical reassessments by doctors are classified as chargeable consultation services. Conversely, patients enrolled in staged medication collection for long-term prescriptions will not incur added consultation fees for scheduled pharmacy refills. Healthcare users and legal representatives should monitor future biennial reviews conducted by the HA regarding potential adjustments to outpatient medication charging units.

### Questions & Answers

**Q: Why are patients charged an outpatient consultation fee when requesting extra medication after rescheduling an appointment without seeing a doctor face to face?**

A: Even when a face-to-face visit does not occur, a doctor is legally and clinically required to review the patient's medical history and reassess their clinical condition to confirm that the medication remains suitable before issuing a prescription. Because this record review and clinical assessment constitute consultation services, the outpatient consultation fee applies.

**Q: Under what circumstances can consultation fees for rescheduled prescriptions be waived?**

A: Consultation fees can be waived in exceptional circumstances where the rescheduling is not due to the patient's personal reasons, such as when clinic services are suspended due to severe weather.

**Q: How does "staged medication collection" differ regarding fee collection?**

A: In staged medication collection, prescribed drugs are dispensed in installments for chronic patients with long-term prescriptions. Patients pay the associated consultation fee only upon initial submission of the prescription. No additional consultation fees are charged for subsequent refill collections because no further medical consultation is involved.

**Q: What is the chargeable unit for prescribed outpatient medication, and how often is it reviewed?**

A: The chargeable unit for each prescribed drug under the public healthcare fee reform is four weeks (reduced from 16 weeks). The HA reviews charging units and models biennially under an established mechanism.

Who May Be Affected

Patients utilizing Hospital Authority public healthcare services, low-income households, chronic illness patients, and healthcare administrators in Hong Kong SAR.

Cross-Border Context

Not specified in the source text.

What to check next

  • Future biennial review announcements by the Hospital Authority regarding medication charging units and models.

This article provides general information and does not constitute legal advice. Consult the official text and obtain advice appropriate to your circumstances where needed.

Keep the issues that matter to you in view

Subscribe to SCLA updates and choose your interests.